Literature DB >> 12539906

A comparison of substance abuse among female offender subtypes.

Julia A Phillips1, Sara Jo Nixon, Betty Pfefferbaum.   

Abstract

The relationship between substance abuse and female criminal offending has been understudied. To aid in clarification of this relation, substance use histories of female offender subtypes were compared. Participants were 152 female prison inmates subgrouped on the basis of offense category: violent (n = 79), property (n = 39), and drug (n = 34). As hypothesized, substance use histories differed across offender subgroups. Violent offenders were most clearly distinguished from other offender subgroups. The data provide evidence linking alcohol, combined cocaine and alcohol, and marijuana misuse with serious violent offending among women and show that violent offenders, compared with other offender subgroups, perceive less association between alcohol consumption and alcohol-related negative consequences.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12539906

Source DB:  PubMed          Journal:  J Am Acad Psychiatry Law        ISSN: 1093-6793


  3 in total

1.  Posttraumatic stress disorder (PTSD) symptoms mediate the relationship between substance misuse and violent offending among female prisoners.

Authors:  Ruth Howard; Thanos Karatzias; Kevin Power; Adam Mahoney
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-10-21       Impact factor: 4.328

2.  Three brief alcohol screens for detecting hazardous drinking in incarcerated women.

Authors:  Celeste M Caviness; Christina Hatgis; Bradley J Anderson; Cynthia Rosengard; Susan M Kiene; Peter D Friedmann; Michael D Stein
Journal:  J Stud Alcohol Drugs       Date:  2009-01       Impact factor: 2.582

3.  Drug-related disorders and the criminal and clinical background of the prison population of São Paulo State, Brazil.

Authors:  Maíra Mendes dos Santos; Maria Ines Quintana; Fernanda Gonçalves Moreira; José Geraldo Vernet Taborda; Jair de Jesus Mari; Sérgio Baxter Andreoli
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.